May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Detection of disease–specific cysteine protease inhibitors in tears.
Author Affiliations & Notes
  • H. Shiota
    Ophthalmology/Vis Neurosci, Univ Tokushima, Tokushima, Japan
  • M. Ishimura
    Ophthalmology/Vis Neurosci, Univ Tokushima, Tokushima, Japan
  • T. Miyamoto
    Ophthalmology/Vis Neurosci, Univ Tokushima, Tokushima, Japan
  • S. Takano
    Ophthalmology/Vis Neurosci, Univ Tokushima, Tokushima, Japan
  • E. Sano
    Institute of Health Science, Tokushima Bunri University, Tokushima, Japan
  • Q.T. Le
    Institute of Health Science, Tokushima Bunri University, Tokushima, Japan
  • N. Katunuma
    Institute of Health Science, Tokushima Bunri University, Tokushima, Japan
  • Footnotes
    Commercial Relationships  H. Shiota, None; M. Ishimura, None; T. Miyamoto, None; S. Takano, None; E. Sano, None; Q.T. Le, None; N. Katunuma, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 626. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Shiota, M. Ishimura, T. Miyamoto, S. Takano, E. Sano, Q.T. Le, N. Katunuma; Detection of disease–specific cysteine protease inhibitors in tears. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):626.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Cysteine protease is one of the essential protein for bacteria and viruses to live. Detection of cysteine protease inhibitors in human tears of normal people, Behcet's disease and Harada's disease was done at the molecular level. Methods: Tears of normal people, Behcet's disease and Harada's disease were taken with glass–capillaries. After diluting these tears 2 times with Tris–buffer, reverse zymography for the detection of cysteine protease inhibitors developed by Katunuma was done. The structures of inhibitors were determined by the method of amino acid sequence analysis. The antibody for 31 kDa detected later was taken from immunized rabbits and the confirmation was done by western blatting method. Results: 1) Three kinds of cysteine protease inhibitors were detected in normal tear. They were cystatin S of 15 kDa, von Ebner's gland protein of 20 kDa and lactoferrin of 72 kDa. 2) New cysteine protease inhibitor of 31 kDa was found in Behcet's disease. 3) Another new cysteine protease inhibitor of 65 kDa was found in Harada's disease. 4) The antibody was confirmed as specific to the 31 kDa. Conclusions: 1) The three kinds of cysteine protease inhibitors in tears will be working as anti–infectious components. 2) New cysteine protease inhibitors of 31 kDa and 65 kDa are disease–specific proteins for Behcet's disease and Harada's disease, respectively. 3) These specific proteins will give us accurate and easy diagnostic kits and help us to understand the pathogenesis of these diseases.

Keywords: autoimmune disease • lacrimal gland • protein purification and characterization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×